nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—panic disorder—Bupropion—obesity	0.312	1	CpDpCtD
Fluvoxamine—SLC6A4—obesity	0.0797	0.511	CbGaD
Fluvoxamine—CYP2E1—obesity	0.0763	0.489	CbGaD
Fluvoxamine—SLC6A3—Diethylpropion—obesity	0.0374	0.1	CbGbCtD
Fluvoxamine—SLC6A3—Sibutramine—obesity	0.0284	0.0758	CbGbCtD
Fluvoxamine—SLC6A3—Phendimetrazine—obesity	0.0284	0.0758	CbGbCtD
Fluvoxamine—SLC6A4—Sibutramine—obesity	0.0248	0.0663	CbGbCtD
Fluvoxamine—SLC6A3—Benzphetamine—obesity	0.0215	0.0575	CbGbCtD
Fluvoxamine—SLC6A3—Phentermine—obesity	0.0215	0.0575	CbGbCtD
Fluvoxamine—SLC6A3—Phenylpropanolamine—obesity	0.0205	0.0548	CbGbCtD
Fluvoxamine—SLC6A4—Phentermine—obesity	0.0188	0.0503	CbGbCtD
Fluvoxamine—SLC6A3—Bupropion—obesity	0.0183	0.0489	CbGbCtD
Fluvoxamine—SLC6A3—Methamphetamine—obesity	0.0172	0.0459	CbGbCtD
Fluvoxamine—SLC6A4—Methamphetamine—obesity	0.015	0.0402	CbGbCtD
Fluvoxamine—CYP2B6—Benzphetamine—obesity	0.00976	0.0261	CbGbCtD
Fluvoxamine—CYP2E1—Bupropion—obesity	0.00841	0.0225	CbGbCtD
Fluvoxamine—CYP2B6—Bupropion—obesity	0.0083	0.0222	CbGbCtD
Fluvoxamine—CYP3A7—Cimetidine—obesity	0.0064	0.0171	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Cimetidine—obesity	0.0064	0.0171	CbGbCtD
Fluvoxamine—CYP2E1—Cimetidine—obesity	0.00618	0.0165	CbGbCtD
Fluvoxamine—CYP1A2—Phentermine—obesity	0.00572	0.0153	CbGbCtD
Fluvoxamine—CYP1A2—Phenylpropanolamine—obesity	0.00546	0.0146	CbGbCtD
Fluvoxamine—CYP2C9—Phentermine—obesity	0.00516	0.0138	CbGbCtD
Fluvoxamine—CYP1A2—Bupropion—obesity	0.00487	0.013	CbGbCtD
Fluvoxamine—CYP3A5—Cimetidine—obesity	0.0048	0.0128	CbGbCtD
Fluvoxamine—CYP2D6—Phentermine—obesity	0.00472	0.0126	CbGbCtD
Fluvoxamine—CYP2C9—Bupropion—obesity	0.00438	0.0117	CbGbCtD
Fluvoxamine—CYP2D6—Bupropion—obesity	0.00401	0.0107	CbGbCtD
Fluvoxamine—CYP3A4—Sibutramine—obesity	0.00396	0.0106	CbGbCtD
Fluvoxamine—CYP2C19—Cimetidine—obesity	0.00387	0.0104	CbGbCtD
Fluvoxamine—CYP2D6—Methamphetamine—obesity	0.00377	0.0101	CbGbCtD
Fluvoxamine—CYP1A2—Cimetidine—obesity	0.00357	0.00955	CbGbCtD
Fluvoxamine—CYP2C9—Cimetidine—obesity	0.00322	0.00861	CbGbCtD
Fluvoxamine—ABCB1—Cimetidine—obesity	0.00312	0.00835	CbGbCtD
Fluvoxamine—CYP3A4—Benzphetamine—obesity	0.003	0.00802	CbGbCtD
Fluvoxamine—CYP2D6—Cimetidine—obesity	0.00294	0.00787	CbGbCtD
Fluvoxamine—CYP3A4—Bupropion—obesity	0.00255	0.00682	CbGbCtD
Fluvoxamine—CYP2C19—Topiramate—obesity	0.00253	0.00678	CbGbCtD
Fluvoxamine—CYP3A4—Orlistat—obesity	0.00208	0.00556	CbGbCtD
Fluvoxamine—CYP3A4—Cimetidine—obesity	0.00187	0.005	CbGbCtD
Fluvoxamine—CYP3A4—Topiramate—obesity	0.00122	0.00328	CbGbCtD
Fluvoxamine—SLC6A3—hindbrain—obesity	0.000501	0.0529	CbGeAlD
Fluvoxamine—SLC6A4—hindbrain—obesity	0.00046	0.0484	CbGeAlD
Fluvoxamine—SLC6A3—respiratory system—obesity	0.000306	0.0323	CbGeAlD
Fluvoxamine—SIGMAR1—islet of Langerhans—obesity	0.000295	0.0311	CbGeAlD
Fluvoxamine—SLC6A4—respiratory system—obesity	0.000281	0.0296	CbGeAlD
Fluvoxamine—CYP3A7—endocrine gland—obesity	0.000273	0.0288	CbGeAlD
Fluvoxamine—CYP3A7—liver—obesity	0.000247	0.026	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal cortex—obesity	0.000234	0.0247	CbGeAlD
Fluvoxamine—CYP2D6—hindbrain—obesity	0.000222	0.0234	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—liver—obesity	0.00021	0.0221	CbGeAlD
Fluvoxamine—CYP3A5—islet of Langerhans—obesity	0.000194	0.0205	CbGeAlD
Fluvoxamine—CYP1A2—respiratory system—obesity	0.00019	0.02	CbGeAlD
Fluvoxamine—SIGMAR1—pituitary gland—obesity	0.000189	0.0199	CbGeAlD
Fluvoxamine—SIGMAR1—adipose tissue—obesity	0.000188	0.0198	CbGeAlD
Fluvoxamine—CYP1A1—respiratory system—obesity	0.000187	0.0198	CbGeAlD
Fluvoxamine—CYP3A5—respiratory system—obesity	0.000183	0.0193	CbGeAlD
Fluvoxamine—CYP2B6—respiratory system—obesity	0.000182	0.0192	CbGeAlD
Fluvoxamine—SLC6A4—digestive system—obesity	0.000178	0.0188	CbGeAlD
Fluvoxamine—CYP2E1—respiratory system—obesity	0.000171	0.018	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal gland—obesity	0.000169	0.0178	CbGeAlD
Fluvoxamine—CYP2B6—adrenal cortex—obesity	0.000153	0.0161	CbGeAlD
Fluvoxamine—CYP2C19—digestive system—obesity	0.000148	0.0156	CbGeAlD
Fluvoxamine—SLC6A4—endocrine gland—obesity	0.000147	0.0155	CbGeAlD
Fluvoxamine—CYP2B6—cardiovascular system—obesity	0.000139	0.0147	CbGeAlD
Fluvoxamine—CYP2C9—cardiovascular system—obesity	0.000138	0.0146	CbGeAlD
Fluvoxamine—SIGMAR1—liver—obesity	0.000132	0.0139	CbGeAlD
Fluvoxamine—CYP2E1—cardiovascular system—obesity	0.000131	0.0138	CbGeAlD
Fluvoxamine—CYP1A1—adipose tissue—obesity	0.000127	0.0133	CbGeAlD
Fluvoxamine—CYP3A5—adipose tissue—obesity	0.000124	0.013	CbGeAlD
Fluvoxamine—CYP2C19—endocrine gland—obesity	0.000122	0.0129	CbGeAlD
Fluvoxamine—CYP1A2—digestive system—obesity	0.000121	0.0127	CbGeAlD
Fluvoxamine—CYP1A1—digestive system—obesity	0.000119	0.0126	CbGeAlD
Fluvoxamine—CYP3A5—digestive system—obesity	0.000116	0.0123	CbGeAlD
Fluvoxamine—CYP2B6—digestive system—obesity	0.000116	0.0122	CbGeAlD
Fluvoxamine—CYP2C9—digestive system—obesity	0.000115	0.0121	CbGeAlD
Fluvoxamine—CYP2B6—adrenal gland—obesity	0.00011	0.0116	CbGeAlD
Fluvoxamine—CYP2C19—liver—obesity	0.00011	0.0116	CbGeAlD
Fluvoxamine—CYP2E1—digestive system—obesity	0.000109	0.0115	CbGeAlD
Fluvoxamine—CYP2E1—adrenal gland—obesity	0.000104	0.0109	CbGeAlD
Fluvoxamine—ABCB1—islet of Langerhans—obesity	0.000103	0.0109	CbGeAlD
Fluvoxamine—CYP1A2—endocrine gland—obesity	9.98e-05	0.0105	CbGeAlD
Fluvoxamine—CYP1A1—endocrine gland—obesity	9.84e-05	0.0104	CbGeAlD
Fluvoxamine—ABCB1—respiratory system—obesity	9.73e-05	0.0103	CbGeAlD
Fluvoxamine—CYP3A5—endocrine gland—obesity	9.62e-05	0.0101	CbGeAlD
Fluvoxamine—CYP2B6—endocrine gland—obesity	9.56e-05	0.0101	CbGeAlD
Fluvoxamine—CYP2C9—endocrine gland—obesity	9.47e-05	0.00999	CbGeAlD
Fluvoxamine—CYP1A2—liver—obesity	9e-05	0.00948	CbGeAlD
Fluvoxamine—CYP2E1—endocrine gland—obesity	8.98e-05	0.00946	CbGeAlD
Fluvoxamine—CYP1A1—liver—obesity	8.87e-05	0.00936	CbGeAlD
Fluvoxamine—CYP3A4—digestive system—obesity	8.74e-05	0.00921	CbGeAlD
Fluvoxamine—CYP3A5—liver—obesity	8.68e-05	0.00915	CbGeAlD
Fluvoxamine—CYP2B6—liver—obesity	8.62e-05	0.00909	CbGeAlD
Fluvoxamine—CYP2D6—digestive system—obesity	8.6e-05	0.00907	CbGeAlD
Fluvoxamine—CYP2C9—liver—obesity	8.54e-05	0.009	CbGeAlD
Fluvoxamine—ABCB1—adrenal cortex—obesity	8.17e-05	0.00861	CbGeAlD
Fluvoxamine—CYP2E1—liver—obesity	8.09e-05	0.00853	CbGeAlD
Fluvoxamine—ABCB1—cardiovascular system—obesity	7.45e-05	0.00786	CbGeAlD
Fluvoxamine—CYP3A4—endocrine gland—obesity	7.22e-05	0.00761	CbGeAlD
Fluvoxamine—CYP2D6—endocrine gland—obesity	7.11e-05	0.00749	CbGeAlD
Fluvoxamine—ABCB1—pituitary gland—obesity	6.6e-05	0.00696	CbGeAlD
Fluvoxamine—ABCB1—adipose tissue—obesity	6.57e-05	0.00693	CbGeAlD
Fluvoxamine—CYP3A4—liver—obesity	6.51e-05	0.00687	CbGeAlD
Fluvoxamine—CYP2D6—liver—obesity	6.41e-05	0.00676	CbGeAlD
Fluvoxamine—ABCB1—digestive system—obesity	6.19e-05	0.00652	CbGeAlD
Fluvoxamine—ABCB1—adrenal gland—obesity	5.9e-05	0.00622	CbGeAlD
Fluvoxamine—ABCB1—endocrine gland—obesity	5.11e-05	0.00539	CbGeAlD
Fluvoxamine—ABCB1—liver—obesity	4.61e-05	0.00486	CbGeAlD
Fluvoxamine—Tension—Bupropion—obesity	4.05e-05	0.000384	CcSEcCtD
Fluvoxamine—Dysgeusia—Bupropion—obesity	4.04e-05	0.000383	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Topiramate—obesity	4.03e-05	0.000382	CcSEcCtD
Fluvoxamine—Arthralgia—Sibutramine—obesity	4.03e-05	0.000382	CcSEcCtD
Fluvoxamine—Chest pain—Sibutramine—obesity	4.03e-05	0.000382	CcSEcCtD
Fluvoxamine—Myalgia—Sibutramine—obesity	4.03e-05	0.000382	CcSEcCtD
Fluvoxamine—Anxiety—Sibutramine—obesity	4.02e-05	0.000381	CcSEcCtD
Fluvoxamine—Nervousness—Bupropion—obesity	4.01e-05	0.00038	CcSEcCtD
Fluvoxamine—Oedema—Orlistat—obesity	3.99e-05	0.000378	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Orlistat—obesity	3.99e-05	0.000378	CcSEcCtD
Fluvoxamine—Back pain—Bupropion—obesity	3.99e-05	0.000378	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Topiramate—obesity	3.99e-05	0.000378	CcSEcCtD
Fluvoxamine—Discomfort—Sibutramine—obesity	3.98e-05	0.000377	CcSEcCtD
Fluvoxamine—Hypokalaemia—Topiramate—obesity	3.97e-05	0.000376	CcSEcCtD
Fluvoxamine—Muscle spasms—Bupropion—obesity	3.97e-05	0.000376	CcSEcCtD
Fluvoxamine—Infection—Orlistat—obesity	3.97e-05	0.000376	CcSEcCtD
Fluvoxamine—Breast disorder—Topiramate—obesity	3.95e-05	0.000374	CcSEcCtD
Fluvoxamine—Dry mouth—Sibutramine—obesity	3.94e-05	0.000373	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Topiramate—obesity	3.93e-05	0.000372	CcSEcCtD
Fluvoxamine—Nervous system disorder—Orlistat—obesity	3.92e-05	0.000371	CcSEcCtD
Fluvoxamine—Confusional state—Sibutramine—obesity	3.9e-05	0.000369	CcSEcCtD
Fluvoxamine—Vision blurred—Bupropion—obesity	3.89e-05	0.000368	CcSEcCtD
Fluvoxamine—Tremor—Bupropion—obesity	3.87e-05	0.000366	CcSEcCtD
Fluvoxamine—Gastritis—Topiramate—obesity	3.86e-05	0.000366	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Sibutramine—obesity	3.86e-05	0.000366	CcSEcCtD
Fluvoxamine—Oedema—Sibutramine—obesity	3.86e-05	0.000366	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Orlistat—obesity	3.86e-05	0.000366	CcSEcCtD
Fluvoxamine—Muscular weakness—Topiramate—obesity	3.85e-05	0.000365	CcSEcCtD
Fluvoxamine—Infection—Sibutramine—obesity	3.84e-05	0.000364	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Bupropion—obesity	3.83e-05	0.000363	CcSEcCtD
Fluvoxamine—Anaemia—Bupropion—obesity	3.82e-05	0.000361	CcSEcCtD
Fluvoxamine—Shock—Sibutramine—obesity	3.8e-05	0.00036	CcSEcCtD
Fluvoxamine—Abdominal distension—Topiramate—obesity	3.8e-05	0.00036	CcSEcCtD
Fluvoxamine—Agitation—Bupropion—obesity	3.79e-05	0.000359	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Sibutramine—obesity	3.78e-05	0.000358	CcSEcCtD
Fluvoxamine—Asthma—Topiramate—obesity	3.77e-05	0.000358	CcSEcCtD
Fluvoxamine—Dysphagia—Topiramate—obesity	3.77e-05	0.000358	CcSEcCtD
Fluvoxamine—Angioedema—Bupropion—obesity	3.77e-05	0.000357	CcSEcCtD
Fluvoxamine—Tachycardia—Sibutramine—obesity	3.77e-05	0.000357	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Sibutramine—obesity	3.74e-05	0.000354	CcSEcCtD
Fluvoxamine—Malaise—Bupropion—obesity	3.72e-05	0.000353	CcSEcCtD
Fluvoxamine—Vertigo—Bupropion—obesity	3.71e-05	0.000351	CcSEcCtD
Fluvoxamine—Syncope—Bupropion—obesity	3.7e-05	0.000351	CcSEcCtD
Fluvoxamine—Pancreatitis—Topiramate—obesity	3.7e-05	0.000351	CcSEcCtD
Fluvoxamine—Leukopenia—Bupropion—obesity	3.7e-05	0.00035	CcSEcCtD
Fluvoxamine—Anorexia—Sibutramine—obesity	3.68e-05	0.000349	CcSEcCtD
Fluvoxamine—Sweating increased—Topiramate—obesity	3.68e-05	0.000348	CcSEcCtD
Fluvoxamine—Angina pectoris—Topiramate—obesity	3.68e-05	0.000348	CcSEcCtD
Fluvoxamine—Palpitations—Bupropion—obesity	3.65e-05	0.000346	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Orlistat—obesity	3.64e-05	0.000345	CcSEcCtD
Fluvoxamine—Bronchitis—Topiramate—obesity	3.63e-05	0.000344	CcSEcCtD
Fluvoxamine—Loss of consciousness—Bupropion—obesity	3.63e-05	0.000344	CcSEcCtD
Fluvoxamine—Abdominal discomfort—Topiramate—obesity	3.62e-05	0.000343	CcSEcCtD
Fluvoxamine—Insomnia—Orlistat—obesity	3.61e-05	0.000342	CcSEcCtD
Fluvoxamine—Hypotension—Sibutramine—obesity	3.61e-05	0.000342	CcSEcCtD
Fluvoxamine—Cough—Bupropion—obesity	3.6e-05	0.000341	CcSEcCtD
Fluvoxamine—Paraesthesia—Orlistat—obesity	3.59e-05	0.00034	CcSEcCtD
Fluvoxamine—Convulsion—Bupropion—obesity	3.58e-05	0.000339	CcSEcCtD
Fluvoxamine—Hypertension—Bupropion—obesity	3.56e-05	0.000338	CcSEcCtD
Fluvoxamine—Dysuria—Topiramate—obesity	3.53e-05	0.000334	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Sibutramine—obesity	3.52e-05	0.000333	CcSEcCtD
Fluvoxamine—Dyspepsia—Orlistat—obesity	3.51e-05	0.000333	CcSEcCtD
Fluvoxamine—Arthralgia—Bupropion—obesity	3.51e-05	0.000333	CcSEcCtD
Fluvoxamine—Myalgia—Bupropion—obesity	3.51e-05	0.000333	CcSEcCtD
Fluvoxamine—Chest pain—Bupropion—obesity	3.51e-05	0.000333	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Topiramate—obesity	3.51e-05	0.000332	CcSEcCtD
Fluvoxamine—Anxiety—Bupropion—obesity	3.5e-05	0.000332	CcSEcCtD
Fluvoxamine—Insomnia—Sibutramine—obesity	3.5e-05	0.000331	CcSEcCtD
Fluvoxamine—Pollakiuria—Topiramate—obesity	3.49e-05	0.00033	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Topiramate—obesity	3.48e-05	0.000329	CcSEcCtD
Fluvoxamine—Discomfort—Bupropion—obesity	3.47e-05	0.000329	CcSEcCtD
Fluvoxamine—Decreased appetite—Orlistat—obesity	3.47e-05	0.000329	CcSEcCtD
Fluvoxamine—Paraesthesia—Sibutramine—obesity	3.47e-05	0.000329	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Orlistat—obesity	3.45e-05	0.000327	CcSEcCtD
Fluvoxamine—Dyspnoea—Sibutramine—obesity	3.45e-05	0.000326	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Topiramate—obesity	3.45e-05	0.000326	CcSEcCtD
Fluvoxamine—Fatigue—Orlistat—obesity	3.44e-05	0.000326	CcSEcCtD
Fluvoxamine—Dry mouth—Bupropion—obesity	3.44e-05	0.000326	CcSEcCtD
Fluvoxamine—Somnolence—Sibutramine—obesity	3.44e-05	0.000325	CcSEcCtD
Fluvoxamine—Weight increased—Topiramate—obesity	3.44e-05	0.000325	CcSEcCtD
Fluvoxamine—Weight decreased—Topiramate—obesity	3.41e-05	0.000323	CcSEcCtD
Fluvoxamine—Pain—Orlistat—obesity	3.41e-05	0.000323	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Topiramate—obesity	3.4e-05	0.000322	CcSEcCtD
Fluvoxamine—Dyspepsia—Sibutramine—obesity	3.4e-05	0.000322	CcSEcCtD
Fluvoxamine—Confusional state—Bupropion—obesity	3.4e-05	0.000322	CcSEcCtD
Fluvoxamine—Pneumonia—Topiramate—obesity	3.38e-05	0.000321	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Bupropion—obesity	3.37e-05	0.000319	CcSEcCtD
Fluvoxamine—Oedema—Bupropion—obesity	3.37e-05	0.000319	CcSEcCtD
Fluvoxamine—Decreased appetite—Sibutramine—obesity	3.36e-05	0.000318	CcSEcCtD
Fluvoxamine—Depression—Topiramate—obesity	3.36e-05	0.000318	CcSEcCtD
Fluvoxamine—Infection—Bupropion—obesity	3.35e-05	0.000317	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Topiramate—obesity	3.34e-05	0.000316	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Sibutramine—obesity	3.34e-05	0.000316	CcSEcCtD
Fluvoxamine—Shock—Bupropion—obesity	3.31e-05	0.000314	CcSEcCtD
Fluvoxamine—Renal failure—Topiramate—obesity	3.31e-05	0.000313	CcSEcCtD
Fluvoxamine—Pain—Sibutramine—obesity	3.3e-05	0.000313	CcSEcCtD
Fluvoxamine—Constipation—Sibutramine—obesity	3.3e-05	0.000313	CcSEcCtD
Fluvoxamine—Nervous system disorder—Bupropion—obesity	3.3e-05	0.000313	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Topiramate—obesity	3.3e-05	0.000312	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Bupropion—obesity	3.3e-05	0.000312	CcSEcCtD
Fluvoxamine—Feeling abnormal—Orlistat—obesity	3.29e-05	0.000312	CcSEcCtD
Fluvoxamine—Tachycardia—Bupropion—obesity	3.29e-05	0.000311	CcSEcCtD
Fluvoxamine—Stomatitis—Topiramate—obesity	3.28e-05	0.000311	CcSEcCtD
Fluvoxamine—Conjunctivitis—Topiramate—obesity	3.27e-05	0.00031	CcSEcCtD
Fluvoxamine—Urinary tract infection—Topiramate—obesity	3.27e-05	0.00031	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Orlistat—obesity	3.27e-05	0.000309	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Bupropion—obesity	3.26e-05	0.000308	CcSEcCtD
Fluvoxamine—Anorexia—Bupropion—obesity	3.21e-05	0.000304	CcSEcCtD
Fluvoxamine—Haematuria—Topiramate—obesity	3.21e-05	0.000304	CcSEcCtD
Fluvoxamine—Feeling abnormal—Sibutramine—obesity	3.18e-05	0.000302	CcSEcCtD
Fluvoxamine—Epistaxis—Topiramate—obesity	3.17e-05	0.000301	CcSEcCtD
Fluvoxamine—Urticaria—Orlistat—obesity	3.17e-05	0.0003	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Sibutramine—obesity	3.16e-05	0.000299	CcSEcCtD
Fluvoxamine—Sinusitis—Topiramate—obesity	3.16e-05	0.000299	CcSEcCtD
Fluvoxamine—Abdominal pain—Orlistat—obesity	3.16e-05	0.000299	CcSEcCtD
Fluvoxamine—Body temperature increased—Orlistat—obesity	3.16e-05	0.000299	CcSEcCtD
Fluvoxamine—Hypotension—Bupropion—obesity	3.15e-05	0.000298	CcSEcCtD
Fluvoxamine—Agranulocytosis—Topiramate—obesity	3.14e-05	0.000297	CcSEcCtD
Fluvoxamine—Bradycardia—Topiramate—obesity	3.08e-05	0.000291	CcSEcCtD
Fluvoxamine—Urticaria—Sibutramine—obesity	3.07e-05	0.000291	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Bupropion—obesity	3.07e-05	0.000291	CcSEcCtD
Fluvoxamine—Abdominal pain—Sibutramine—obesity	3.05e-05	0.000289	CcSEcCtD
Fluvoxamine—Body temperature increased—Sibutramine—obesity	3.05e-05	0.000289	CcSEcCtD
Fluvoxamine—Insomnia—Bupropion—obesity	3.05e-05	0.000289	CcSEcCtD
Fluvoxamine—Haemoglobin—Topiramate—obesity	3.04e-05	0.000288	CcSEcCtD
Fluvoxamine—Rhinitis—Topiramate—obesity	3.03e-05	0.000287	CcSEcCtD
Fluvoxamine—Paraesthesia—Bupropion—obesity	3.03e-05	0.000287	CcSEcCtD
Fluvoxamine—Hepatitis—Topiramate—obesity	3.02e-05	0.000286	CcSEcCtD
Fluvoxamine—Haemorrhage—Topiramate—obesity	3.02e-05	0.000286	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Topiramate—obesity	3.01e-05	0.000285	CcSEcCtD
Fluvoxamine—Hallucination—Topiramate—obesity	3.01e-05	0.000285	CcSEcCtD
Fluvoxamine—Dyspnoea—Bupropion—obesity	3e-05	0.000284	CcSEcCtD
Fluvoxamine—Pharyngitis—Topiramate—obesity	3e-05	0.000284	CcSEcCtD
Fluvoxamine—Somnolence—Bupropion—obesity	3e-05	0.000284	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Topiramate—obesity	2.98e-05	0.000283	CcSEcCtD
Fluvoxamine—Oedema peripheral—Topiramate—obesity	2.98e-05	0.000282	CcSEcCtD
Fluvoxamine—Dyspepsia—Bupropion—obesity	2.97e-05	0.000281	CcSEcCtD
Fluvoxamine—Urethral disorder—Topiramate—obesity	2.96e-05	0.000281	CcSEcCtD
Fluvoxamine—Hypersensitivity—Orlistat—obesity	2.94e-05	0.000279	CcSEcCtD
Fluvoxamine—Decreased appetite—Bupropion—obesity	2.93e-05	0.000277	CcSEcCtD
Fluvoxamine—Visual impairment—Topiramate—obesity	2.91e-05	0.000276	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Bupropion—obesity	2.91e-05	0.000275	CcSEcCtD
Fluvoxamine—Fatigue—Bupropion—obesity	2.9e-05	0.000275	CcSEcCtD
Fluvoxamine—Constipation—Bupropion—obesity	2.88e-05	0.000273	CcSEcCtD
Fluvoxamine—Pain—Bupropion—obesity	2.88e-05	0.000273	CcSEcCtD
Fluvoxamine—Asthenia—Orlistat—obesity	2.86e-05	0.000271	CcSEcCtD
Fluvoxamine—Erythema multiforme—Topiramate—obesity	2.86e-05	0.000271	CcSEcCtD
Fluvoxamine—Hypersensitivity—Sibutramine—obesity	2.85e-05	0.00027	CcSEcCtD
Fluvoxamine—Pruritus—Orlistat—obesity	2.83e-05	0.000268	CcSEcCtD
Fluvoxamine—Eye disorder—Topiramate—obesity	2.82e-05	0.000267	CcSEcCtD
Fluvoxamine—Tinnitus—Topiramate—obesity	2.82e-05	0.000267	CcSEcCtD
Fluvoxamine—Cardiac disorder—Topiramate—obesity	2.8e-05	0.000266	CcSEcCtD
Fluvoxamine—Feeling abnormal—Bupropion—obesity	2.78e-05	0.000263	CcSEcCtD
Fluvoxamine—Asthenia—Sibutramine—obesity	2.77e-05	0.000263	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Bupropion—obesity	2.75e-05	0.000261	CcSEcCtD
Fluvoxamine—Angiopathy—Topiramate—obesity	2.74e-05	0.00026	CcSEcCtD
Fluvoxamine—Pruritus—Sibutramine—obesity	2.73e-05	0.000259	CcSEcCtD
Fluvoxamine—Diarrhoea—Orlistat—obesity	2.73e-05	0.000259	CcSEcCtD
Fluvoxamine—Chills—Topiramate—obesity	2.71e-05	0.000257	CcSEcCtD
Fluvoxamine—Urticaria—Bupropion—obesity	2.68e-05	0.000254	CcSEcCtD
Fluvoxamine—Alopecia—Topiramate—obesity	2.67e-05	0.000253	CcSEcCtD
Fluvoxamine—Body temperature increased—Bupropion—obesity	2.66e-05	0.000252	CcSEcCtD
Fluvoxamine—Abdominal pain—Bupropion—obesity	2.66e-05	0.000252	CcSEcCtD
Fluvoxamine—Mental disorder—Topiramate—obesity	2.65e-05	0.000251	CcSEcCtD
Fluvoxamine—Diarrhoea—Sibutramine—obesity	2.64e-05	0.00025	CcSEcCtD
Fluvoxamine—Dizziness—Orlistat—obesity	2.64e-05	0.00025	CcSEcCtD
Fluvoxamine—Malnutrition—Topiramate—obesity	2.63e-05	0.000249	CcSEcCtD
Fluvoxamine—Flatulence—Topiramate—obesity	2.59e-05	0.000245	CcSEcCtD
Fluvoxamine—Tension—Topiramate—obesity	2.58e-05	0.000244	CcSEcCtD
Fluvoxamine—Dysgeusia—Topiramate—obesity	2.58e-05	0.000244	CcSEcCtD
Fluvoxamine—Dizziness—Sibutramine—obesity	2.56e-05	0.000242	CcSEcCtD
Fluvoxamine—Nervousness—Topiramate—obesity	2.55e-05	0.000242	CcSEcCtD
Fluvoxamine—Back pain—Topiramate—obesity	2.54e-05	0.000241	CcSEcCtD
Fluvoxamine—Vomiting—Orlistat—obesity	2.54e-05	0.00024	CcSEcCtD
Fluvoxamine—Muscle spasms—Topiramate—obesity	2.53e-05	0.000239	CcSEcCtD
Fluvoxamine—Rash—Orlistat—obesity	2.52e-05	0.000238	CcSEcCtD
Fluvoxamine—Dermatitis—Orlistat—obesity	2.52e-05	0.000238	CcSEcCtD
Fluvoxamine—Headache—Orlistat—obesity	2.5e-05	0.000237	CcSEcCtD
Fluvoxamine—Hypersensitivity—Bupropion—obesity	2.48e-05	0.000235	CcSEcCtD
Fluvoxamine—Vision blurred—Topiramate—obesity	2.48e-05	0.000235	CcSEcCtD
Fluvoxamine—Tremor—Topiramate—obesity	2.46e-05	0.000233	CcSEcCtD
Fluvoxamine—Vomiting—Sibutramine—obesity	2.46e-05	0.000233	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Topiramate—obesity	2.44e-05	0.000231	CcSEcCtD
Fluvoxamine—Rash—Sibutramine—obesity	2.44e-05	0.000231	CcSEcCtD
Fluvoxamine—Dermatitis—Sibutramine—obesity	2.43e-05	0.000231	CcSEcCtD
Fluvoxamine—Anaemia—Topiramate—obesity	2.43e-05	0.00023	CcSEcCtD
Fluvoxamine—Headache—Sibutramine—obesity	2.42e-05	0.000229	CcSEcCtD
Fluvoxamine—Asthenia—Bupropion—obesity	2.42e-05	0.000229	CcSEcCtD
Fluvoxamine—Agitation—Topiramate—obesity	2.42e-05	0.000229	CcSEcCtD
Fluvoxamine—Pruritus—Bupropion—obesity	2.38e-05	0.000226	CcSEcCtD
Fluvoxamine—Nausea—Orlistat—obesity	2.37e-05	0.000225	CcSEcCtD
Fluvoxamine—Malaise—Topiramate—obesity	2.37e-05	0.000225	CcSEcCtD
Fluvoxamine—Vertigo—Topiramate—obesity	2.36e-05	0.000224	CcSEcCtD
Fluvoxamine—Syncope—Topiramate—obesity	2.36e-05	0.000223	CcSEcCtD
Fluvoxamine—Leukopenia—Topiramate—obesity	2.35e-05	0.000223	CcSEcCtD
Fluvoxamine—Palpitations—Topiramate—obesity	2.32e-05	0.00022	CcSEcCtD
Fluvoxamine—Loss of consciousness—Topiramate—obesity	2.31e-05	0.000219	CcSEcCtD
Fluvoxamine—Diarrhoea—Bupropion—obesity	2.31e-05	0.000218	CcSEcCtD
Fluvoxamine—Nausea—Sibutramine—obesity	2.3e-05	0.000217	CcSEcCtD
Fluvoxamine—Cough—Topiramate—obesity	2.29e-05	0.000217	CcSEcCtD
Fluvoxamine—Convulsion—Topiramate—obesity	2.28e-05	0.000216	CcSEcCtD
Fluvoxamine—Hypertension—Topiramate—obesity	2.27e-05	0.000215	CcSEcCtD
Fluvoxamine—Chest pain—Topiramate—obesity	2.24e-05	0.000212	CcSEcCtD
Fluvoxamine—Arthralgia—Topiramate—obesity	2.24e-05	0.000212	CcSEcCtD
Fluvoxamine—Myalgia—Topiramate—obesity	2.24e-05	0.000212	CcSEcCtD
Fluvoxamine—Anxiety—Topiramate—obesity	2.23e-05	0.000211	CcSEcCtD
Fluvoxamine—Dizziness—Bupropion—obesity	2.23e-05	0.000211	CcSEcCtD
Fluvoxamine—Discomfort—Topiramate—obesity	2.21e-05	0.00021	CcSEcCtD
Fluvoxamine—Dry mouth—Topiramate—obesity	2.19e-05	0.000207	CcSEcCtD
Fluvoxamine—Confusional state—Topiramate—obesity	2.16e-05	0.000205	CcSEcCtD
Fluvoxamine—Oedema—Topiramate—obesity	2.15e-05	0.000203	CcSEcCtD
Fluvoxamine—Vomiting—Bupropion—obesity	2.14e-05	0.000203	CcSEcCtD
Fluvoxamine—Infection—Topiramate—obesity	2.13e-05	0.000202	CcSEcCtD
Fluvoxamine—Rash—Bupropion—obesity	2.12e-05	0.000201	CcSEcCtD
Fluvoxamine—Dermatitis—Bupropion—obesity	2.12e-05	0.000201	CcSEcCtD
Fluvoxamine—Shock—Topiramate—obesity	2.11e-05	0.0002	CcSEcCtD
Fluvoxamine—Headache—Bupropion—obesity	2.11e-05	0.0002	CcSEcCtD
Fluvoxamine—Nervous system disorder—Topiramate—obesity	2.1e-05	0.000199	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Topiramate—obesity	2.1e-05	0.000199	CcSEcCtD
Fluvoxamine—Tachycardia—Topiramate—obesity	2.09e-05	0.000198	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Topiramate—obesity	2.07e-05	0.000197	CcSEcCtD
Fluvoxamine—Anorexia—Topiramate—obesity	2.05e-05	0.000194	CcSEcCtD
Fluvoxamine—Hypotension—Topiramate—obesity	2.01e-05	0.00019	CcSEcCtD
Fluvoxamine—Nausea—Bupropion—obesity	2e-05	0.00019	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Topiramate—obesity	1.96e-05	0.000185	CcSEcCtD
Fluvoxamine—Insomnia—Topiramate—obesity	1.94e-05	0.000184	CcSEcCtD
Fluvoxamine—Paraesthesia—Topiramate—obesity	1.93e-05	0.000183	CcSEcCtD
Fluvoxamine—Dyspnoea—Topiramate—obesity	1.91e-05	0.000181	CcSEcCtD
Fluvoxamine—Somnolence—Topiramate—obesity	1.91e-05	0.000181	CcSEcCtD
Fluvoxamine—Dyspepsia—Topiramate—obesity	1.89e-05	0.000179	CcSEcCtD
Fluvoxamine—Decreased appetite—Topiramate—obesity	1.87e-05	0.000177	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Topiramate—obesity	1.85e-05	0.000176	CcSEcCtD
Fluvoxamine—Fatigue—Topiramate—obesity	1.85e-05	0.000175	CcSEcCtD
Fluvoxamine—Pain—Topiramate—obesity	1.84e-05	0.000174	CcSEcCtD
Fluvoxamine—Constipation—Topiramate—obesity	1.84e-05	0.000174	CcSEcCtD
Fluvoxamine—Feeling abnormal—Topiramate—obesity	1.77e-05	0.000168	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Topiramate—obesity	1.76e-05	0.000166	CcSEcCtD
Fluvoxamine—Urticaria—Topiramate—obesity	1.71e-05	0.000162	CcSEcCtD
Fluvoxamine—Abdominal pain—Topiramate—obesity	1.7e-05	0.000161	CcSEcCtD
Fluvoxamine—Body temperature increased—Topiramate—obesity	1.7e-05	0.000161	CcSEcCtD
Fluvoxamine—Hypersensitivity—Topiramate—obesity	1.58e-05	0.00015	CcSEcCtD
Fluvoxamine—Asthenia—Topiramate—obesity	1.54e-05	0.000146	CcSEcCtD
Fluvoxamine—Pruritus—Topiramate—obesity	1.52e-05	0.000144	CcSEcCtD
Fluvoxamine—Diarrhoea—Topiramate—obesity	1.47e-05	0.000139	CcSEcCtD
Fluvoxamine—Dizziness—Topiramate—obesity	1.42e-05	0.000134	CcSEcCtD
Fluvoxamine—Vomiting—Topiramate—obesity	1.36e-05	0.000129	CcSEcCtD
Fluvoxamine—Rash—Topiramate—obesity	1.35e-05	0.000128	CcSEcCtD
Fluvoxamine—Dermatitis—Topiramate—obesity	1.35e-05	0.000128	CcSEcCtD
Fluvoxamine—Headache—Topiramate—obesity	1.34e-05	0.000127	CcSEcCtD
Fluvoxamine—Nausea—Topiramate—obesity	1.27e-05	0.000121	CcSEcCtD
Fluvoxamine—CYP1A2—Metabolism—CYP2E1—obesity	1.55e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOB—obesity	1.55e-06	3.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PRKAR2B—obesity	1.55e-06	3.58e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AGT—obesity	1.55e-06	3.58e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GNAS—obesity	1.54e-06	3.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DCN—obesity	1.54e-06	3.56e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CB—obesity	1.53e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NQO1—obesity	1.53e-06	3.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—obesity	1.52e-06	3.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—COMT—obesity	1.52e-06	3.51e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—obesity	1.51e-06	3.51e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOB—obesity	1.51e-06	3.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—COMT—obesity	1.5e-06	3.48e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—obesity	1.5e-06	3.47e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.5e-06	3.47e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOA1—obesity	1.5e-06	3.47e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CPT1A—obesity	1.5e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GNB3—obesity	1.49e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARGC1A—obesity	1.49e-06	3.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—obesity	1.49e-06	3.44e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.49e-06	3.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GNB3—obesity	1.48e-06	3.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARGC1A—obesity	1.48e-06	3.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CG—obesity	1.48e-06	3.43e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—LPL—obesity	1.48e-06	3.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—obesity	1.47e-06	3.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GCG—obesity	1.47e-06	3.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—SLC2A4—obesity	1.47e-06	3.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NAMPT—obesity	1.47e-06	3.39e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LIPC—obesity	1.46e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCK—obesity	1.46e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GNAS—obesity	1.45e-06	3.37e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CG—obesity	1.45e-06	3.36e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYCS—obesity	1.45e-06	3.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOC3—obesity	1.45e-06	3.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CG—obesity	1.45e-06	3.35e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—LPL—obesity	1.44e-06	3.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—obesity	1.44e-06	3.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GNAS—obesity	1.44e-06	3.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.43e-06	3.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—obesity	1.43e-06	3.31e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOB—obesity	1.42e-06	3.3e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT1—obesity	1.42e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT1—obesity	1.42e-06	3.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOB—obesity	1.41e-06	3.27e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—obesity	1.41e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—obesity	1.41e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CETP—obesity	1.41e-06	3.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CD36—obesity	1.41e-06	3.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—obesity	1.4e-06	3.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NCOA1—obesity	1.4e-06	3.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—obesity	1.4e-06	3.24e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—obesity	1.4e-06	3.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SDC1—obesity	1.39e-06	3.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—STK11—obesity	1.38e-06	3.2e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP19A1—obesity	1.38e-06	3.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—obesity	1.38e-06	3.2e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—obesity	1.38e-06	3.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—obesity	1.37e-06	3.18e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CD36—obesity	1.37e-06	3.17e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—obesity	1.37e-06	3.17e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKR1C3—obesity	1.37e-06	3.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CG—obesity	1.37e-06	3.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LPL—obesity	1.36e-06	3.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LPL—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SCARB1—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—obesity	1.33e-06	3.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—obesity	1.33e-06	3.07e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—obesity	1.32e-06	3.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—obesity	1.32e-06	3.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SREBF1—obesity	1.31e-06	3.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARA—obesity	1.31e-06	3.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CD—obesity	1.3e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—obesity	1.3e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—obesity	1.3e-06	3.01e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—obesity	1.29e-06	3e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CD36—obesity	1.29e-06	2.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALB—obesity	1.28e-06	2.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—COMT—obesity	1.28e-06	2.97e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CD36—obesity	1.28e-06	2.97e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARA—obesity	1.27e-06	2.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CD—obesity	1.27e-06	2.95e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CD—obesity	1.27e-06	2.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT2—obesity	1.27e-06	2.94e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARGC1A—obesity	1.27e-06	2.93e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GNB3—obesity	1.27e-06	2.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AGT—obesity	1.27e-06	2.93e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—obesity	1.26e-06	2.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALB—obesity	1.26e-06	2.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALB—obesity	1.26e-06	2.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FASN—obesity	1.24e-06	2.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—obesity	1.24e-06	2.87e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BCHE—obesity	1.24e-06	2.87e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AGT—obesity	1.23e-06	2.86e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GNAS—obesity	1.23e-06	2.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3R1—obesity	1.23e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—obesity	1.23e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—obesity	1.23e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOA1—obesity	1.23e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—obesity	1.22e-06	2.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—obesity	1.21e-06	2.81e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—obesity	1.21e-06	2.8e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOB—obesity	1.21e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3R1—obesity	1.2e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—obesity	1.2e-06	2.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CD—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARA—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3R1—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—obesity	1.2e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOA1—obesity	1.2e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2E1—obesity	1.2e-06	2.77e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARA—obesity	1.19e-06	2.76e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALB—obesity	1.19e-06	2.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NQO1—obesity	1.18e-06	2.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.17e-06	2.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AGT—obesity	1.16e-06	2.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AGT—obesity	1.15e-06	2.67e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LPL—obesity	1.15e-06	2.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—obesity	1.14e-06	2.64e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3R1—obesity	1.13e-06	2.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—obesity	1.13e-06	2.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CB—obesity	1.13e-06	2.63e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCG—obesity	1.13e-06	2.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—SLC2A4—obesity	1.13e-06	2.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—obesity	1.13e-06	2.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—obesity	1.13e-06	2.61e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOA1—obesity	1.13e-06	2.61e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—obesity	1.12e-06	2.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—obesity	1.12e-06	2.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—obesity	1.12e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CG—obesity	1.12e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYCS—obesity	1.12e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOA1—obesity	1.12e-06	2.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CB—obesity	1.11e-06	2.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CB—obesity	1.11e-06	2.57e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—obesity	1.1e-06	2.55e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—obesity	1.1e-06	2.54e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT1—obesity	1.1e-06	2.54e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT1—obesity	1.1e-06	2.54e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CD36—obesity	1.09e-06	2.53e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CG—obesity	1.09e-06	2.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NCOA1—obesity	1.08e-06	2.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—obesity	1.08e-06	2.5e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.07e-06	2.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP19A1—obesity	1.07e-06	2.47e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—STK11—obesity	1.07e-06	2.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—obesity	1.06e-06	2.47e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—obesity	1.06e-06	2.45e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—obesity	1.05e-06	2.44e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CB—obesity	1.05e-06	2.42e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—obesity	1.04e-06	2.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—obesity	1.04e-06	2.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—obesity	1.04e-06	2.4e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—obesity	1.03e-06	2.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CG—obesity	1.03e-06	2.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CG—obesity	1.02e-06	2.36e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARA—obesity	1.02e-06	2.36e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—obesity	9.93e-07	2.3e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—COMT—obesity	9.91e-07	2.29e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AGT—obesity	9.86e-07	2.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—obesity	9.85e-07	2.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CD—obesity	9.83e-07	2.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—obesity	9.79e-07	2.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GNB3—obesity	9.77e-07	2.26e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARGC1A—obesity	9.77e-07	2.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—obesity	9.74e-07	2.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—obesity	9.72e-07	2.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—obesity	9.71e-07	2.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALB—obesity	9.71e-07	2.25e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—obesity	9.66e-07	2.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—obesity	9.66e-07	2.24e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CD—obesity	9.6e-07	2.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—obesity	9.57e-07	2.22e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOA1—obesity	9.55e-07	2.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GNAS—obesity	9.51e-07	2.2e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALB—obesity	9.48e-07	2.19e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PIK3CA—obesity	9.35e-07	2.16e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOB—obesity	9.31e-07	2.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3R1—obesity	9.29e-07	2.15e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—obesity	9.29e-07	2.15e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.14e-07	2.12e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3R1—obesity	9.06e-07	2.1e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—obesity	9.06e-07	2.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CD—obesity	9.05e-07	2.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CD—obesity	8.97e-07	2.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALB—obesity	8.93e-07	2.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPL—obesity	8.89e-07	2.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALB—obesity	8.85e-07	2.05e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CG—obesity	8.72e-07	2.02e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—obesity	8.68e-07	2.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CB—obesity	8.57e-07	1.98e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3R1—obesity	8.54e-07	1.98e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—obesity	8.54e-07	1.98e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—obesity	8.49e-07	1.97e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3R1—obesity	8.47e-07	1.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—obesity	8.47e-07	1.96e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CD36—obesity	8.45e-07	1.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—obesity	8.41e-07	1.95e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CB—obesity	8.37e-07	1.94e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—obesity	8.3e-07	1.92e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—obesity	8.29e-07	1.92e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—obesity	8.25e-07	1.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—obesity	8.01e-07	1.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CB—obesity	7.88e-07	1.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARA—obesity	7.86e-07	1.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CB—obesity	7.82e-07	1.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—obesity	7.81e-07	1.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—obesity	7.74e-07	1.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CD—obesity	7.66e-07	1.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—obesity	7.64e-07	1.77e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AGT—obesity	7.61e-07	1.76e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALB—obesity	7.56e-07	1.75e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—obesity	7.45e-07	1.73e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—obesity	7.39e-07	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOA1—obesity	7.37e-07	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—obesity	7.24e-07	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3R1—obesity	7.24e-07	1.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PIK3CA—obesity	6.92e-07	1.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PIK3CA—obesity	6.77e-07	1.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PIK3CA—obesity	6.76e-07	1.56e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CG—obesity	6.73e-07	1.56e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CB—obesity	6.68e-07	1.55e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—obesity	6.62e-07	1.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—obesity	6.49e-07	1.5e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—obesity	6.4e-07	1.48e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PIK3CA—obesity	6.39e-07	1.48e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—obesity	6.37e-07	1.47e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CD—obesity	5.91e-07	1.37e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALB—obesity	5.84e-07	1.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—obesity	5.65e-07	1.31e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—obesity	5.58e-07	1.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3R1—obesity	5.58e-07	1.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—obesity	5.53e-07	1.28e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—obesity	5.52e-07	1.28e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PIK3CA—obesity	5.23e-07	1.21e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—obesity	5.22e-07	1.21e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CB—obesity	5.15e-07	1.19e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—obesity	5.11e-07	1.18e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PIK3CA—obesity	5.1e-07	1.18e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PIK3CA—obesity	4.81e-07	1.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PIK3CA—obesity	4.76e-07	1.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—obesity	4.27e-07	9.88e-06	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—obesity	4.17e-07	9.65e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PIK3CA—obesity	4.07e-07	9.43e-06	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—obesity	3.93e-07	9.09e-06	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—obesity	3.89e-07	9.01e-06	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—obesity	3.33e-07	7.7e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PIK3CA—obesity	3.14e-07	7.27e-06	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—obesity	2.57e-07	5.94e-06	CbGpPWpGaD
